Autopsy report · NCT06036485

Efficacy of Kerecis Omega 3 in Comparison to Clinical Standard Procedures

“Lack of funding to support the study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Insel Gruppe AG, University Hospital Bern

Sponsor type

University, hospital or other

Conditions

Leg Ulcer

Interventions

Kerecis Omega 3; Surgical debridement

Participants

0

Trials that died the same way

• Study of EQU-001 for Uncontrolled Focal Onset Seizures
  “insufficient funding to complete the study” (91% match in meaning)
• Midodrine Use in Septic Shock
  “No funding for the study; not enough staff” (88% match in meaning)
• Regulation of the Release of Inflammatory Mediators From Blood Leukocytes
  “No funding for the study” (87% match in meaning)
• Dim Light at Night in Patients With Obstructive Sleep Apnea
  “The study was stopped due to lack of funding.” (84% match in meaning)
• A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
  “The study is closed due to lack of funding to support the study.” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.